We are live on ! Find out more
HCMT

Highland Capital Management (Texas) Portfolio holdings

AUM $39M
This Fund
S&P 500
This Quarter Est. Return
-1.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
+$105M
Cap. Flow
+$158M
Cap. Flow %
9.22%
Top 10 Hldgs %
44.34%
Holding
408
New
98
Increased
45
Reduced
65
Closed
96

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$27.6M
2
NXRT
NexPoint Residential Trust
NXRT
+$23.8M
3
FTNT icon
Fortinet
FTNT
+$22.4M
4
ET icon
Energy Transfer Partners
ET
+$15.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$10.6M
2
VST icon
Vistra
VST
+$7.46M
3
AAL icon
American Airlines Group
AAL
+$7.31M
4
MLNX
Mellanox Technologies, Ltd.
MLNX
+$6.27M
5
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$6.01M

Sector Composition

Rank Sector Weight
1 Energy 13.75%
2 Technology 13.1%
3 Utilities 12%
4 Real Estate 8.78%
5 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
226
Autodesk
ADSK
$53.9B
$815K 0.05%
5,000
-8,000
-62% -$1.35M
PFX icon
227
PhenixFIN
PFX
$90.3M
$784K 0.05%
16,755
– –
MU icon
228
Micron Technology
MU
$991B
$772K 0.05%
20,000
-35,000
-64% -$1.33M
INSM icon
229
Insmed
INSM
$29.1B
$768K 0.04%
30,000
+5,000
+20% +$139K
MHK icon
230
Mohawk Industries
MHK
$9.08B
$737K 0.04%
+5,000
New +$692K
SSNC icon
231
SS&C Technologies
SSNC
$18.7B
$732K 0.04%
12,700
– –
INN
232
Summit Hotel Properties
INN
$673M
$719K 0.04%
62,680
– –
PCRX icon
233
Pacira BioSciences
PCRX
$970M
$707K 0.04%
16,250
– –
CTRL
234
DELISTED
Control4 Corporation
CTRL
$707K 0.04%
+29,768
New +$624K
VRS
235
DELISTED
Verso Corporation
VRS
$688K 0.04%
36,114
– –
PAA icon
236
Plains All American Pipeline
PAA
$16.3B
$665K 0.04%
27,291
– –
QHC
237
DELISTED
Quorum Health Corporation
QHC
$642K 0.04%
461,523
-3,000
-0.6% -$4.92K
LJPC
238
DELISTED
La Jolla Pharmaceutical Company
LJPC
$635K 0.04%
68,700
– –
AZN icon
239
AstraZeneca
AZN
$251B
$619K 0.04%
7,500
+2,500
+50% +$196K
SUN icon
240
Sunoco
SUN
$13.6B
$603K 0.04%
19,285
– –
CJ
241
DELISTED
C&J Energy Services, Inc.
CJ
$603K 0.04%
51,208
+24,208
+90% +$331K
HYACU
242
DELISTED
Haymaker Acquisition Corp. II Unit
HYACU
$592K 0.03%
+58,000
New +$587K
ANIP icon
243
ANI Pharmaceuticals
ANIP
$1.71B
$584K 0.03%
7,100
– –
SAIC icon
244
Saic
SAIC
$5.36B
$584K 0.03%
6,750
– –
APC
245
DELISTED
Anadarko Petroleum
APC
$579K 0.03%
+8,200
New +$550K
NKLA
246
DELISTED
Nikola Corporation Common Stock
NKLA
$577K 0.03%
+1,900
New +$574K
PRAH
247
DELISTED
PRA Health Sciences, Inc.
PRAH
$569K 0.03%
5,735
– –
CNNE icon
248
Cannae Holdings
CNNE
$640M
$553K 0.03%
19,070
– –
MCK icon
249
McKesson
MCK
$103B
$538K 0.03%
4,000
– –
AHT
250
Ashford Hospitality Trust
AHT
$20.5M
$524K 0.03%
+179
New +$838K
8 9
10
11 12

Similar funds

DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
KA
KSL Advisors Denver, Colorado $16.1M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM

Highland Capital Management (Texas)'s Q2 2019 Portfolio in Review

As of Q2 2019, Highland Capital Management (Texas) held 408 positions worth $1.71B, up 6.6% from $1.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Highland Capital Management (Texas) deployed $158M of net new capital in Q2 2019, opening 98 new positions and adding to 45 existing holdings. Its largest new stake was Bristol-Myers Squibb: 318,200 shares worth $14.4M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, up from 12% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.

  • Highland Capital Management (Texas)'s largest Q2 2019 buy was Bristol-Myers Squibb: 318,200 shares worth $14.4M.
  • Highland Capital Management (Texas) added most to Pioneer Natural Resource Co. in Q2 2019, an estimated $27.6M increase.
  • Highland Capital Management (Texas)'s biggest Q2 2019 reduction was Intel, cutting an estimated $10.6M.
  • Highland Capital Management (Texas) fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $6.27M.
  • Highland Capital Management (Texas)'s ten largest holdings make up 44% of its $1.71B portfolio in Q2 2019.
  • Highland Capital Management (Texas) opened 98 new positions and closed 96 in Q2 2019.
  • Highland Capital Management (Texas)'s portfolio value rose 6.6% quarter-over-quarter to $1.71B.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.